Indonesia’s Health Ministry is actively promoting the development of stem cell therapy, but with a strong emphasis on patient safety and evidence-based practices. Director Yanti Herman stresses the need for rigorous scientific evaluation and adherence to established protocols to mitigate risks associated with unproven treatments. This push comes amid growing public interest and the proliferation of unregulated stem cell clinics. The ministry aims to create a clearer regulatory framework and guidelines for stem cell therapy providers. This includes ensuring clinics utilize validated methods and transparently inform patients about potential benefits and risks. Ultimately, the goal is to foster innovation while safeguarding public health and building trust in this promising field of medicine. Collaboration with research institutions and international experts is also being encouraged to facilitate advancements.